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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S107differences were found between limbs for the external sagittal and
frontal plane moments at the hip joint, subjects demonstrated greater
external adduction moment at the knee of the SX side compared to the
NSX side (MD: 0.12  0.11 Nm/Kg, p¼.013, d¼1.09).
Conclusions: The Hip Harris Score, pain level, and abductor strength
suggest that the SX hip is more impaired than the NSX limb. Subjects
also ambulate with a compensatory lateral trunk lean toward the
affected limb, but continue to demonstrate greater adduction angles on
the SX limb during single limb stance. These movement abnormalities
may represent the primary movement impairments and may be related
to the unilateral hip abductor weakness observed in this sample.
Unilateral impairments may also contribute to the signiﬁcantly larger
knee adduction moment on the NSX limb.Figure 1. Average trunk lean angle (A) and hip frontal plane angle (B) during the
stance phase of gait for the surgical limb (solid black line) and non-surgical limb
(dashed red line). Positive angles represent lean toward the stance leg (A) and
adduction (B). Black-striped area represents the standard deviation for the surgical
limb. Red-squared area represents the standard deviation for the non-surgical limb.185
THE TRANSIENT EFFECTS OF COX-2 INHIBITOR ON OSTEOGENIC
DIFFERENTIATION IN CANINE BONE MARROW-DERIVED
MESENCHYMAL STEM CELLS
N. Oh, T. Sunaga, S. Kim, K. Hosoya, M. Okumura. Hokkaido Univ.,
Sapporo, Japan
Purpose: Nonsteroidal anti-inﬂammatory drugs (NSAIDs), especially
cyclooxygenase (COX)-2 inhibitors, are simple and effective analgesics
in orthopedic ﬁelds. Last decades, the effects of COX-2 inhibitor on bone
healing process have remained controversial, while rare clinical data
represent relationship between COX-2 inhibitor and bone healing. The
aim of this study was to assess the effects of COX-2 inhibitors, such as
carprofen (Cp) and meloxicam (Mx), on osteogenic differentiation of
canine bone marrow-derived mesenchymal stem cells (BMSCs).
Methods: Canine BMSCs were harvested from three one-year-old
female beagle dogs. Osteogenic differentiation of canine BMSCs was
induced by osteogenic medium containing dexamethasone (100 nM), b-
glycerophosphate (10 mM), ascorbic acid (50 mg/ml) and human
recombinant IL-1b (1 ng/ml) as an inﬂammatory stimulator. The
maximum concentration of Cp (10 mM) or Mx (10 mM) that had no effect
on cell viability was treated within short- and long-term of osteogenic
process. The mRNA expressions of osteoblastic marker, involving alka-
line phosphatase (ALP) and osteocalcin, and prostaglandin E2 receptor
subtypes, such as EP2 and EP4, were measured using quantitative
reverse transcription-polymerase chain reaction (qRT-PCR). For the
histological evaluation, ALP staining and von Kossa staining were
performed.
Results: Expressions of mRNA of ALP and osteocalcin were signiﬁcantly
suppressed by use of COX-2 inhibitors. Alkaline phosphatase staining
revealed that COX-2 inhibitors partially arrested early differentiation of
osteoblast lineage. However, gene expressions of EP2 and EP4 were up-
regulated under COX-2 inhibition, and delayed osteogenic differentia-
tion was gradually recovered after withdrawal of COX-2 inhibitors.
Calciﬁcation of matrix showed no signiﬁcant difference between short-
term treated group and control at the late period of osteogenic
differentiation.
Conclusions: These data suggest that canine BMSCs might have
potential to catch-up the osteogenic differentiation and to up-regulate
osteogenic gene expression after withdrawal of COX-2 inhibitors.186
IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-18 AS
A MOLECULE TO PROTECT AND REGENERATE ARTICULAR CARTILAGE
Y. Mori y, T. Saito y, C. Ladel z, H. Guehring z, U-i. Chung y,
H. Kawaguchi y. y Faculty of Med., Univ. of Tokyo, Tokyo, Japan; zMerck
KGaA, Darmstadt, Germany
Purpose: Aiming at the disease-modifying treatment of osteoarthritis
(OA), we sought to identify genes that maintain the homeostasis of
adult articular cartilage and regenerate its lesions by gene expression
proﬁle analyses. The mechanisms of the identiﬁed molecule underlying
the protection and regeneration were further investigated.
Methods: To identify genes that have both protective and regenerative
effects on adult articular cartilage, we performed two sets of microarray
analyses. First, to select genes that work for maintenance of articular
cartilage, we compared gene expression proﬁles between adult artic-
ular (AA) and adult growth plate (AG) cartilages in 10-week-old rats.
Second, to ﬁnd genes that function for regeneration of articular carti-
lage, we compared the proﬁles between infant superﬁcial (IS) and infant
deep (ID) layers of epiphyseal cartilage in 6-day-old rats. For genes
which were up-regulated 10-fold both in AA than in AG and in IS than
in ID, we performed real-time RT-PCR for the conﬁrmation. In vivo
expression was examined by immunohistochemistry of articular and
growth plate cartilage of 14-week-old rats. The therapeutic effect of
intra-articular injection of sprifermin (recombinant human ﬁbroblast
growth factor 18 (FGF18)) was examined in the experimental OA model
by surgical induction of instability in the knee joints of adult rats. To
further learn the underlying mechanism, the protective ability of
articular cartilage was assessed by measuring the amount of sulfated
glycosaminoglycan (sGAG) released into the medium in the ex vivo
culture of bilateral femoral heads of 3-week-old mice using dimethyl-
methylene blue dye-binding assay. Proliferation and migration were
analyzed in the cultures of mouse articular chondrocytes using Cell
Counting Kit-8 and Oris Cell Migration assay systems, respectively.
Expression levels of catabolism-related factors (Mmp9, Mmp13,
Adamts4, Adamts5, Timp1, Timp2, and Timp3) and anabolism-related
factors (Col2a1 and aggrecan) in the cultures of mouse femoral heads
and mouse articular chondrocytes were analyzed by real-time RT-PCR.
Results: Microarray analyses revealed that 40 and 186 genes had 10-
fold higher expression ratios of AA/AG and IS/ID, respectively, and 16
genes showed 10-fold of both AA/AG and IS/ID ratios. The ratios of the
16 genes were conﬁrmed to be 10 fold by real-time RT-PCR analysis.
Among them three genes were expressed more strongly in AA than in
IS. In these three genes, FGF18 was the extracellular and secreted factor
of which the AA/AG ratio was the highest in the microarray analysis.
Immunohistochemistry showed that FGF18 was strongly expressed in
the articular cartilage chondrocytes of adult rats but was hardly
detected in the growth plate cartilage. In the rat surgical OA model,
a once-weekly injection of sprifermin given 3 weeks post-surgery
prevented cartilage degeneration in a dose-dependent manner at 6 and
9 weeks after surgery, with a signiﬁcant effect at 10 mg/week of spri-
fermin. As an underlying mechanism, sprifermin suppressed the sGAG
release into the culture medium in the ex vivo culture of mouse femoral
heads. Furthermore, sprifermin accelerated proliferation and migration
of cultured mouse articular chondrocytes. Among catabolic and
anabolic factors, sprifermin decreased Adamts4 and increased Timp1
expressions in the cultures of mouse femoral heads and murine artic-
ular chondrocytes; however it decreased Col2a1 and aggrecan expres-
sions in both cultures.
Conclusions: The present gene expression proﬁling analysis identiﬁed
sprifermin as a molecule to protect and regenerate adult articular
cartilage, causing prevention of cartilage degeneration by the once-
weekly intra-articular injection in a rat model. This effect may be due to
inhibition of cartilage catabolism, and acceleration of proliferation and
migration of articular chondrocytes, providing a disease-modifying OA
treatment.
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OLD AND YOUNG ARTICULAR CARTILAGE RESPOND EQUIVALENTLY
FOR PHYSIOLOGICAL AND EXCESSIVE LOADING BY ACTIVATION OF
PROTECTIVE TGF-BETA SIGNALING
W. Madej y, A. van Caam z, P. van der Kraan z, P. Buma y. yOrthopedie Res.
Laboratorium, Radboud Univ. Nijmegen Med. Ctr., Nijmegen, The
Netherlands; zRheumatology Res. and Advanced Therapeutics, Radboud
Univ. Nijmegen Med. Ctr., Nijmegen, The Netherlands
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S108Purpose: (Partial) Meniscectomy causes dramatic changes in knee joint
biomechanics. As a consequence, this surgical intervention generally
leads to the development of osteoarthritis (OA). Furthermore, the
majority of reports show that age is one of the most important risk
factors for OA development after meniscectomy. However, the mecha-
nisms how changed loading patterns lead to OA and how age related
changes in articular cartilage inﬂuence its response for increased
loading remains largely unknown.
Our previous ﬁndings showed that in young and healthy articular
cartilage, when subjected to compression, TGF-beta signals via type I
receptor ALK5 causing activation of downstream genes speciﬁc for
Smad2/3 signaling pathway. Since in aged articular cartilage there is
loss of type ALK5 leading to shift towards Smad1/5/8 signaling pathway,
we wanted to investigate how TGF-beta signals in aged articular carti-
lage when subjected to physiological and excessive loading.
Methods: Full-thickness articular cartilage specimens were cored from
metacarpophalangeal joint surface of two different age groups of
cows(juvenile of 1 year old and aged of 8- 12 years old) . All explants
were allowed to equilibrate for 48 h in static, serum free culture
conditions. Explants were divided into two stimulation groups: 30 min
stimulation with 3 MPa (physiological load) and 30 min stimulation
with 12 MPa (excessive load). Unloaded cartilage was used as controls.
Stimulation groups were subjected to sinusoidal compression (1Hz)
using BOSE ElectroForce BioDynamic test system, in culture condi-
tions. After 2 and 6 hours cartilage samples were frozen and mRNA
levels of selected genes were examined using real-time polymerase
chain reaction (RT-PCR).
Results: In 2 hours after the stimulation there was signiﬁcant upregu-
lation of TGF-beta1 in both age groups when stimulated with 3 MPa but
also with 12 MPa compared to the static control. However, in young
articular cartilage this upregulation was more pronounced than in old.
In 6 hours after the stimulation, in young cartilage, TGF-beta was
upregulated in control group (when compared to 2 hours time point),
therefore the effect of stimulation was less pronounced. This was not
the case in aged cartilage where in both stimulation groups TGF-beta
was upregulated when compared to static control.
Examination of TGF-beta signaling pathways downstream genes
expression demonstrated that in 2 hours after the stimulation in both
age groups, 3MPa and 12MPa stimulation caused upregulation of PAI-1.
The level of upregulationwas higher in young articular cartilage but this
could be related to lower PAI1 expression in static controls of young
cartilage. In aged articular cartilage, PAI-1 upregulationwas caused only
by 12MPa stimulation. Stimulationwith both physiological (3 MPa) and
excessive loading (12 MPa) showed no effect on ID1 expression when
measured in 2 hours in both age groups. However in 6 hours after the
stimulation in 12 MPa compression group ID1 was down-regulated in
both age groups.
Conclusions: Unexpectedly many changes in expression of genes
caused by repetitive loading did not depend on the amount of force that
was applied in our experiments.
Mechanical compression with physiological and excessive forces
affected similar TGF-beta-signaling related genes in young and old
cartilage, however, in young cartilage with a greater magnitude.
Although ALK5 expression is decreased in aged articular cartilage,
loading is still able to activate PAI-1, indicating activation of the Smad2/
3 signalling pathway. This indicates similar but not equal stimulation of
TGF-beta signaling in different age groups. Since activation of protective
TGF-beta signalling by loading was higher in young cartilage this might
indicate that the protective effects of laoding are more pronounced in
young cartilage than in old cartilage.188
AMINO ACID RACEMIZATION REVEALS A HIGH STATE OF REPAIR IN
KNEE COMPARED WITH HIP OSTEOARTHRITIC CARTILAGE
J. Catterall, R. Zura, M. Bolognesi, V. Kraus. Duke Univ., Durham, NC, USA
Purpose: After synthesis, proteins undergo age dependent non-enzy-
matic post-translational modiﬁcations such as amino acid racemization
and deamidation. Many cartilage proteins have long half-lives, so are
prone to accumulation of post-translational modiﬁcations with age.
During previous studies we quantiﬁed protein racemization in whole
cartilage; osteoarthritic (OA) cartilage appeared to accumulate race-
mized amino acids at a slower rate than normal cartilage suggesting
higher turnover of cartilage with OA. Our recent work with deamidated
COMP showed greater accumulation of this post-translationallymodiﬁed protein in hip OA than knee OA suggesting higher turnover of
cartilage extracellular matrix in knee joints. The goal of this study is to
conﬁrm and expand upon our earlier investigations of protein turnover
in health and disease through investigation of protein racemization in
soluble (mainly aggrecan) and insoluble (mainly collagen) cartilage
fractions of knee and hip non-OA and OA joints.
Methods:With IRB approval, cartilage was collected at the time of joint
replacement for OA or trauma surgery. OA tissue was split into
macroscopically lesioned and normal (remote from lesion) regions.
Cartilage was pulverized and extracted in 4M guanidine HCl to isolate
soluble proteins; the extracted residual cartilage represented the
insoluble protein fraction. Samples were hydrolyzed in 6M HCl, ﬂuo-
rescently labeled and both the non-racemized (L) and the racemized (D)
forms of the amino acids Asx (Asp and Asn) and Ser were quantiﬁed
using reverse phase HPLC. Data were expressed as a ratio of D/(D+L).
The association of racemized proteinwith agewas determined by linear
regression; statistical differences in racemized protein content between
joint sites was analyzed using a multivariable model with age as
a covariate.
Results: In non-OA cartilage amino acid racemization was associated
with age: insoluble Asx (p¼0.0006, r2¼0.61) and Ser (p¼0.01, r20.39)
and a trend for soluble Asx (p¼0.05, R2¼0.35). Remote OA cartilage from
both joint sites showed similar associations with age: insoluble Asx
(p¼0.0002, R2¼0.32) and Ser (p<0.0001, R2¼0.40) and a trend for
soluble Asx (p¼0.06, R2¼0.09). Lesioned OA cartilage however only
demonstrated a weak association with age based on insoluble Ser
(p¼0.03, R2¼0.16). While hip OA fractions demonstrated signiﬁcant
associations of racemized amino acids with age, no signiﬁcant associ-
ations with age for any of the knee fractions: hip remote insoluble Asx
(p¼0.06, R2¼0.19) and Ser (p¼0.01, R2¼0.34), lesion soluble Asx
(p¼0.03, R2¼0.66) and Ser (p¼0.04, R2¼0.62). Accounting for age, hip
had a signiﬁcantly higher content of racemized amino acids compared
with knee: remote insoluble Asx (p<0.0001) and Ser (p<0.0001),
remote soluble Asx (p¼0.001).
Conclusions: Our data on OA lesional cartilage demonstrates a loss of
the normal age-related increase in racemization that is particularly
striking for the knee. Comparedwith knee, the hip soluble and insoluble
cartilage fractions had a higher content of racemized amino acids. Taken
together, these data strongly suggest that protein turnover increases in
OA, particularly at sites of OA lesions. These data further demonstrate
that hip OA cartilage turns over more slowly than knee OA cartilage;
conversely, these data are compatible with a less robust reparative
anabolic response in hip OA compared with knee OA. These results
suggest that effective treatment of hip OA may require anabolic stimuli
in addition to anti-catabolic stimuli. Effective treatment of knee OAmay
require mainly anti-catabolic treatment strategies given the apparent
underlying evidence of the ongoing repair and high turnover state in
knee OA.
This work was supported by Claude D Pepper OAIC P30 AG028716 and
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PERSISTENT EXPRESSION OF COL2A1 EMBRYONIC ISOFORMS
DISRUPTS CARTILAGE MATRIX ASSEMBLY AND ALTERS BONE
PROPERTIES
S. Ravindran y, L. Wirthlin y, U. Hansen z, M.J. Silva y, R.J. Fernandes x,
A. McAlinden y. yWashington Univ., St Louis, MO, USA; zUniv. of
Muenster, Muenster, Germany; xUniv. of Washington, Seattle, WA, USA
Purpose: To determine how the transition from embryonic (IIA) to
mature (IIB) Col2a1 isoform expression affects skeletal development
and homeostasis. A transgenic mouse model was utilized that has been
engineered to express only embryonic IIA isoforms of Col2a1 during
pre- and post-natal development. The clinical signiﬁcance of this model
is apparent from observations that IIA collagen is expressed in engi-
neered cartilage tissue and re-expressed in human osteoarthritic
articular cartilage.
Methods: A splice site targeting approach was used to generate a global
knock-in mouse model to inhibit the developmentally-regulated IIA-to-
IIB splicing event and drive persistent expression of IIA collagen iso-
forms in vivo. RT-PCR and immunohistochemistry (IHC) was carried out
to determine the Col2a1 splicing patterns in heterozygous (ki/+) and
homozygous (ki/ki) knock-in mice at different time-points of develop-
ment (E12.5 - P70). IIA procollagen processing patterns were analyzed
by Western blotting using an antibody recognizing the exon 2-encoded
